Development of antiviral agents

Selective therapeutic agents are needed to combat epidemic outbreaks of neglected tropical diseases caused by viruses such as Chikungunya, dengue and Zika. Our research targets viral proteases as the Achilles heel of viral replication. We design selective probes and inhibitors that help to characterise and validate proteases as antiviral drug targets and develop lead compounds for drug discovery campaigns.